Published in J Infect Dis on October 01, 1982
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med (1984) 3.31
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest (1983) 2.32
Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res (1989) 1.70
A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med (1990) 1.53
Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci U S A (1987) 1.36
Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol (2006) 1.24
The interferons. Clin Exp Immunol (1983) 1.22
Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PLoS One (2013) 1.19
Markers predicting progression of human immunodeficiency virus-related disease. Clin Microbiol Rev (1994) 1.19
Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med (1983) 1.18
Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures. J Virol (1991) 1.14
Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children? J Clin Microbiol (1990) 1.11
Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120. J Virol (1992) 1.09
Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection. J Clin Microbiol (1989) 1.06
Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages. Proc Natl Acad Sci U S A (1989) 1.05
Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes. J Clin Invest (1985) 1.04
Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations. J Clin Microbiol (1989) 1.03
HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol (2012) 1.03
The acquired immunodeficiency syndrome (AIDS). J Clin Invest (1985) 1.00
Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis. Sci China Life Sci (2010) 0.94
Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection. Clin Diagn Lab Immunol (1995) 0.93
Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome. J Clin Invest (1989) 0.92
Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia. Clin Exp Immunol (1993) 0.90
Mechanisms of Host Resistance Against HIV Infection and Progression to AIDS. Sultan Qaboos Univ Med J (2007) 0.89
Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome. J Clin Invest (1988) 0.88
De novo synthesis and secretion of a 36-kD protein by cells that form lupus inclusions in response to alpha-interferon. J Clin Invest (1995) 0.86
Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus. J Clin Microbiol (1989) 0.86
Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile. J Exp Med (1989) 0.85
Elevated levels of CD4 antigen in sera of human immunodeficiency virus-infected populations. J Clin Microbiol (1990) 0.83
Theoretical implications of cellular immune reactions against helper lymphocytes infected by an immune system retrovirus. Proc Natl Acad Sci U S A (1987) 0.83
Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus. Ann Rheum Dis (1985) 0.82
A reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy). How 'Inflammatory' Cytokines may have A therapeutic Role. Mediators Inflamm (1994) 0.82
The Acquired Immunodeficiency Syndrome: current status. Yale J Biol Med (1983) 0.80
Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1. PLoS One (2012) 0.80
HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms. J Virol (2015) 0.78
CD20 antibody primes B lymphocytes for type I interferon production. PLoS One (2013) 0.78
Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression. Clin Exp Immunol (1987) 0.75
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest (1987) 7.95
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med (1983) 6.67
Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother (1972) 5.86
Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell (1986) 5.79
Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives. Proc Natl Acad Sci U S A (1971) 5.31
Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med (1986) 4.99
Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med (1982) 4.98
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
Risk factors for Kaposi's sarcoma in homosexual men. Lancet (1982) 4.70
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet (1995) 4.31
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 3.67
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med (1993) 3.48
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Replication of semliki forest virus: three forms of viral RNA produced during infection. Proc Natl Acad Sci U S A (1966) 3.23
IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol (1989) 3.15
HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet (1992) 3.09
Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol (1968) 3.04
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis (2001) 2.95
Kaposi's sarcoma in HIV-negative homosexual men. Lancet (1990) 2.80
Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest (1989) 2.69
Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci U S A (1985) 2.65
Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature. Proc Natl Acad Sci U S A (1973) 2.64
Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A (1975) 2.59
Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58
Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol (1997) 2.56
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol (1987) 2.52
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol (1993) 2.47
Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38
Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci U S A (1989) 2.38
Temperature-sensitive viruses and the etiology of chronic and inapparent infections. J Infect Dis (1975) 2.38
Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical. Science (1987) 2.37
Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr (1990) 2.35
Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J (1992) 2.34
Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc Natl Acad Sci U S A (1988) 2.34
Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin. J Exp Med (1984) 2.33
Post-transcriptional control of interferon synthesis. J Virol (1971) 2.30
Cytoplasmic fractions associated with Semliki Forest virus ribonucleic acid replication. J Virol (1967) 2.29
Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science (1994) 2.28
Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun (1986) 2.27
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
Antiviral activity of interferons. Bacteriol Rev (1977) 2.25
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24
Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol (1990) 2.22
A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J Cell Biol (1992) 2.15
Viral specific RNAs in infected cells. Nature (1967) 2.13
Synthesis of human interferon by Xenopus laevis oocytes: two structural genes for interferons in human cells. Proc Natl Acad Sci U S A (1977) 2.12
Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine. Antimicrob Agents Chemother (1979) 2.10
Analysis of arbovirus ribonucleic acid forms by polyacrylamide gel electrophoresis. J Virol (1971) 2.10
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Arch Dermatol (2000) 2.09
Generalized lymphadenopathy in homosexual men. Ann Intern Med (1983) 2.09
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J Virol (1972) 2.00
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
Induction and decay of human fibroblast interferon mRNA. Proc Natl Acad Sci U S A (1977) 1.94
Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem (1988) 1.94
Antigenic analysis of Neisseria gonorrhoeae by crossed immunoelectrophoresis. Infect Immun (1976) 1.93
Partial purification and characterization of human gamma (immune) interferon. Proc Natl Acad Sci U S A (1981) 1.91
Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. J Immunol (1986) 1.91
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst (1991) 1.91
Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol (1983) 1.89
Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds. Antimicrob Agents Chemother (1974) 1.84
Membrane-associated replication complex in arbovirus infection. J Virol (1972) 1.83
Interferon inducers protect mice against plasmodium berghei malaria. Science (1968) 1.83
Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA (2000) 1.79
Patient-applied podofilox for treatment of genital warts. Lancet (1989) 1.79
Ribonucleic acid polymerase catalyzing synthesis of double-stranded arbovirus ribonucleic acid. J Virol (1967) 1.77
Differential effects of actinomycin D and puromycin on the release of interferon induced by double stranded RNA. Nature (1969) 1.77
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol (1990) 1.75
The effect of interferon on the synthesis of RNA in chick cells infected with Semliki forest virus. J Gen Virol (1967) 1.73
The epidemiology of childhood psychiatric disorders: prevalence findings from recent studies. J Am Acad Child Adolesc Psychiatry (1990) 1.73
Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice. Antimicrob Agents Chemother (1975) 1.72
Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. Proc Natl Acad Sci U S A (1984) 1.72
Recombinant human gamma interferon inhibits simian malaria. Infect Immun (1986) 1.71
Interferons with special emphasis on the immune system. Adv Immunol (1983) 1.69
Suppression of human interferon production by inhibitors of glycosylation. Virology (1975) 1.69
Role of temperature-sensitive mutants in persistent infections initiated with vesicular stomatitis virus. J Virol (1976) 1.68
TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol (1996) 1.68
Membrane binding of input arbovirus ribonucleic acid: effect of interferon or cycloheximide. J Virol (1970) 1.66